Real-world India data show trastuzumab emtansine biosimilars deliver meaningful PFS and manageable safety in heavily ...
FDA approval of Filkri expands Accord’s G-CSF biosimilar portfolio, offering a short-acting option for neutropenia in cancer care.
All Things Biosimilars: How Streamlined CES Rules Could Shift the Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results